关注
Carmen Klein Herenbrink
Carmen Klein Herenbrink
在 sund.ku.dk 的电子邮件经过验证
标题
引用次数
引用次数
年份
The role of kinetic context in apparent biased agonism at GPCRs
C Klein Herenbrink, DA Sykes, P Donthamsetti, M Canals, T Coudrat, ...
Nature communications 7 (1), 10842, 2016
3202016
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief
DD Jensen, TM Lieu, ML Halls, NA Veldhuis, WL Imlach, QN Mai, ...
Science Translational Medicine 9 (392), eaal3447, 2017
1922017
Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission
RE Yarwood, WL Imlach, TM Lieu, NA Veldhuis, DD Jensen, ...
Proceedings of the National Academy of Sciences 114 (46), 12309-12314, 2017
1542017
Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome
NN Jimenez-Vargas, LA Pattison, P Zhao, TM Lieu, R Latorre, DD Jensen, ...
Proceedings of the National Academy of Sciences 115 (31), E7438-E7447, 2018
1502018
A structure–activity analysis of biased agonism at the dopamine D2 receptor
J Shonberg, CK Herenbrink, L Lopez, A Christopoulos, PJ Scammells, ...
Journal of medicinal chemistry 56 (22), 9199-9221, 2013
1032013
Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor
M Szabo, C Klein Herenbrink, A Christopoulos, JR Lane, B Capuano
Journal of medicinal chemistry 57 (11), 4924-4939, 2014
882014
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic Ligand
SN Mistry, J Shonberg, CJ Draper-Joyce, C Klein Herenbrink, M Michino, ...
Journal of medicinal chemistry 58 (17), 6819-6843, 2015
542015
A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A2A receptor
JR Lane, CK Herenbrink, GJP Van Westen, JA Spoorendonk, C Hoffmann, ...
Molecular pharmacology 81 (3), 475-487, 2012
532012
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D2 receptor
CJ Draper-Joyce, M Michino, RK Verma, CK Herenbrink, J Shonberg, ...
Biochemical pharmacology 148, 315-328, 2018
282018
Molecular determinants of the intrinsic efficacy of the antipsychotic aripiprazole
C Klein Herenbrink, R Verma, HD Lim, A Kopinathan, A Keen, J Shonberg, ...
ACS chemical biology 14 (8), 1780-1792, 2019
242019
The action of a negative allosteric modulator at the dopamine D2 receptor is dependent upon sodium ions
CJ Draper-Joyce, RK Verma, M Michino, J Shonberg, A Kopinathan, ...
Scientific Reports 8 (1), 1208, 2018
162018
Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors
M Szabo, HD Lim, C Klein Herenbrink, A Christopoulos, JR Lane, ...
Journal of Medicinal Chemistry 58 (3), 1550-1555, 2015
142015
Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensors
C Klein Herenbrink, JF Støier, WD Reith, A Dagra, MAC Gregorek, ...
Communications Biology 5 (1), 578, 2022
132022
Novel fluorescent ligands enable single-molecule localization microscopy of the dopamine transporter
DA Guthrie, C Klein Herenbrink, MD Lycas, T Ku, A Bonifazi, BT DeVree, ...
ACS chemical neuroscience 11 (20), 3288-3300, 2020
112020
The role of kinetic context in apparent biased agonism at GPCRs. Nat Commun 7: 10842
C Klein Herenbrink, DA Sykes, P Donthamsetti, M Canals, T Coudrat, ...
82016
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief. Sci Transl Med 9: eaal3447
DD Jensen, T Lieu, ML Halls, NA Veldhuis, WL Imlach, QN Mai, DP Poole, ...
52017
Membrane curvature association of amphipathic helix 8 drives constitutive GPCR endocytosis
R Herlo, JH Schmidt, J Rombach, AH Larsen, M Stoklund, M Perslev, ...
bioRxiv, 2024.03. 27.587027, 2024
2024
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief
CJH Porter, TM Lieu, DD Jensen, TM Lieu, ML Halls, NA Veldhuis, ...
Science Translational Medicine 9 (392), 2017
2017
The role of kinetic context in apparent biased agonism at GPCRs
JA Javitch, C Klein Herenbrink, DA Sykes, P Donthamsetti, M Canals, ...
Nature Communications 7, 0
Understanding biased agonism at the dopamine D₂ receptor
C Klein Herenbrink
Monash University, 0
系统目前无法执行此操作,请稍后再试。
文章 1–20